Get Well Appoints Thomas Elbert as Chief Operating Officer
Executive brings more than 20 years of healthcare information technology, data architecture, and analytics experience BETHESDA, Md., Nov. 1, 2024...
Day: November 1, 2024
Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024
WOBURN, MA / ACCESSWIRE / November 1, 2024 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing...
UnisLink Earns HITRUST I1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats
HITRUST certification validates that UnisLink is operating with leading security practices to protect sensitive information.PHOENIX, AZ / ACCESSWIRE / November...
Nation’s Largest Pancreatic Cancer Early Detection Study Holds Annual Meeting in San Diego
PRECEDE Study Aims to Increase Early Detection in Pancreatic CancerSAN DIEGO, CA / ACCESSWIRE / November 1, 2024 / Pancreatic...
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
HOUSTON, TX / ACCESSWIRE / November 1, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company...
RTI Surgical Completes Acquisition of Collagen Solutions
RTI Surgical Completes Acquisition of Collagen Solutions ALACHUA, Fla., November 1, 2024 – RTI Surgical ("RTI" or "the Company"), a...
Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control
FemBloc issued patent provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth controlATLANTA, Nov. 01, 2024 (GLOBE...
Galecto Reports Third Quarter 2024 Financial Results
- Completed strategic review to focus on oncology and severe liver diseases - Announced acquisition of global rights to BRM-1420,...
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial
DENVER, Nov. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...
Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial
Bagsværd, Denmark, 1 November 2024 – Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE...
TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update
Conference call to be held Monday, November 4, 2024, at 8:30 AM ETNEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) --...
Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024
BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
The MUHC Foundation and the Beat 92.5’s Raise Craze raises $95,000 to help strike out breast cancer
All funds are supporting breast cancer care at the McGill University Health Centre (MUHC) The MUHC Foundation and the Beat...
Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a...
Invitation to Presentation of Cantargia’s Interim Report January – September 2024
LUND, SE / ACCESSWIRE / November 01, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) invites investors, analysts and...
iZafe Group Q3 Interim Report, July-September 2024
STOCKHOLM, SE / ACCESSWIRE / November 01, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) presents today, November 1,...
Javid Javdani Calls for Increased Support for Small Business Owners in California
San Diego Entrepreneur Highlights the Role of International Food Markets in Cultural Exchange and Community Building SAN DIEGO, CA /...